Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

Donepezil (Aricept) was approved in 1996, Rivastigmine (Exelon) was approved in 2000, and galantamine (Reminyl) was approved in 2001. In October, 2003, the FDA approved Memantine (Namenda) for the ...

Dementia treatment is more than just medication. It can include lifestyle ... Common cholinesterase inhibitors include: glantamine (Razadyne) donepezil (Aricept) rivastigmine (Exelon) You may ...

Aricept (donepezil) is a brand-name drug prescribed for dementia related to Alzheimer’s disease. Aricept has interactions with other drugs and certain supplements. Examples include ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

The UK's drugs regulator—the MHRA—has approved the Alzheimer's drug donanemab, but it won't be available on the NHS. The National Institute for Health and Care Excellence (Nice), which ...

31, 2024 — A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and ...

The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for the disease safe for use but the rationing body has immediately ruled ...

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication. Alzheimer's affects roughly 5.8 million Americans, according to the Centers for Disease ...

Maher, Pamela 2023. Ferroptosis in Health and Disease. p. 461. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ...

24, 2024, showed potentially promising results in Alzheimer's and dementia prevention: It's the third such study that indicates that semaglutides, the active ingredients in weight loss medications ...